Chapter 11: High-Risk Perinatal Care: Preexisting Conditions

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

Today we are undertaking an absolutely vital deep dive into high -risk perinatal care.

We're talking about that clinical reality where a pre -existing chronic condition, you know, anything from a metabolic disorder to serious cardiovascular challenges is superimposed onto a pregnancy.

It's really the ultimate challenge in maternal fetal medicine.

I mean, we celebrate pregnancy as this normal physiologic process, which it is.

Right.

But when you introduce a chronic illness, you create these systemic conflicts.

The mother's body is trying to manage a chronic disease state while also adapting to the massive dynamic changes needed to grow a baby.

And our mission today is pretty laser focused.

We want to distill the highest yield clinical knowledge to promote optimal outcomes for both the pregnant woman and the fetus.

Both.

That's key.

We're going to cut through the noise with a comprehensive review of conditions, metabolic, cardiac, respiratory, neurological, all the way through to substance use disorder.

It's really a roadmap for the whole intraprofessional team.

It's about making sure clinicians understand the specific challenges

and the nursing priorities across the entire perinatal period.

So antepartum, intrapartum, and postpartum.

Exactly.

All three.

And we have to start where the volume is highest.

The sources really stress the rising global prevalence of diabetes mellitus.

The numbers are staggering.

We're talking about 422 million people worldwide.

Wow.

And crucially for our discussion, the prevalence of pregestational diabetes,

that's type one or type two, is just increasing so rapidly among women of reproductive age right here in the US.

Which makes diabetes management an undisputed cornerstone of modern high risk care.

It really is.

So if we had to pull out one single foundational clinical rule from this entire section, what is the key to minimizing risk?

It is without a doubt, strict maternal glucose control.

Okay.

But, and this is the critical part, that mandate doesn't start at conception.

The best outcomes are achieved when that strict control is established before she even gets pregnant.

Before conception.

And then maintained just rigorously throughout the entire pregnancy.

That is the single most important variable that we can actually control.

Okay, so let's unpack the mechanisms behind diabetes mellitus.

Because I think understanding the underlying physiology is so essential before we start layering on the demands of pregnancy.

What is the fundamental defect we're dealing with?

At its core, diabetes mellitus is a group of metabolic diseases that are all unified by one single finding.

Persistent hyperglycemia.

Too much sugar in the blood.

Right.

And this happens because of defects in insulin secretion or defects in how insulin works at the cellular level or very often it's a combination of both.

So insulin is the gatekeeper.

It's the molecular gatekeeper, exactly.

It's the hormone that lets glucose, which is our main fuel, move from the bloodstream into our muscle and fat cells to be used for energy.

And if that gatekeeper is absent or if the lock is broken, the glucose just piles up in the bloodstream.

It piles up.

And that accumulation of glucose is what triggers that classic symptom constellation we all learn about, the three polys.

Polyuria, polydipsia, and polyphagia.

That's right.

The first effect of all that glucose is that the blood becomes hyperosmolar.

It gets thicker, you could say.

And that pulls massive amounts of fluid out of the body cells and into the vascular space.

So right away, you have cellular dehydration.

And the body wants to get rid of that excess sugar and fluid.

Exactly.

So the kidneys start working overtime, excreting huge amounts of urine to try and flush it all out.

And that leads to polyuria.

That's the first poly.

Which then directly leads to the excessive thirst, polydipsia.

It follows right from that.

The cells are screaming for water because they're dehydrated, which triggers the thirst center in the brain.

That's polydipsia.

And the third one, polyphagia or excessive eating.

That's also rooted right in that same malfunction.

Since the cells can't get any glucose for fuel,

the body literally thinks it's starving.

Even though there's plenty of fuel around.

Right.

So it starts breaking down fats and proteins for energy, which causes weight loss.

And that state of cellular starvation makes the person want to eat constantly.

And the chronic, you know, the long -term consequence of this whole uncontrolled process is what creates the major health risks we associate with diabetes.

Exactly.

The microvascular and microvascular changes.

Right.

You see this accelerated premature atherosclerosis that impacts the big vessels.

So the heart.

And critically, you see damage to the microvasculature.

Which leads to?

Retinopathy, damage to the eyes.

Nephropathy, damage to the kidneys.

And neuropathy, which is damage to the nerves.

And when a woman with these pre -existing complications gets pregnant, the risks just escalate dramatically.

Now, in terms of classification, we have the four major types.

But for our purposes in pregnancy, we're mostly concerned with pre -gestational versus gestational diabetes.

Right.

Pre -gestational diabetes is pretty straightforward.

It's type one and type two that existed before she got pregnant.

And type two is the most common?

By far.

90 to 95 % of cases.

Yeah.

It's characterized by insulin resistance and a deficiency in insulin.

Type one is different.

It's the autoimmune destruction of the beta cells leading to an absolute insulin deficiency.

And the key clinical distinction here is that almost all women with pre -gestational diabetes, even if they were managing type two with diet or oral meds before, they're going to need insulin during the pregnancy.

They absolutely will.

The hormonal demands of pregnancy are just too much.

They overwhelm the body's ability to regulate glucose on its own.

And this brings us to a specific tool used in maternal health.

White's classification system.

I know it's been around for a while, but it's still really useful for risk stratification.

It is.

It's still highly relevant.

So how does this system go beyond just saying type one or type two to actually help clinicians predict the risk?

It looks at three main things.

The age of onset, the duration of the disease, and most importantly, the presence of vasculopathy.

So evidence of that long -term end -organ damage we just talked about.

Exactly.

For pre -gestational diabetes, the classes run from B through T.

Class B is relatively mild, but when you start getting into the lower classes, that's where the risk really goes up.

For example?

Class F denotes established diabetic nephropathy, so kidney damage.

Class R means she has retinitis proliferans, which is advanced eye damage.

Class T means the woman has had a renal transplant.

So those classifications immediately signal a vastly increased risk profile for both the mother and the baby.

Immediately.

Put everyone on high alert.

So how does White's system handle gestational diabetes, GDM, which is diagnosed in the second or third trimester?

For GDM, it's much simpler.

It's just split into two classes, A1 and A2.

A1 being?

Class A1 is for women who have those abnormal glucose values but can control their blood sugar with diet and exercise alone.

And A2?

Class A2 means the woman requires medication, either insulin or oral agents, to meet her target glucose goals.

So the need for medication immediately elevates the risk level and the intensity of the fetal surveillance you're going to do?

Precisely.

It's a whole different level of care.

Hashtag tag tag 1 .2 metabolic changes in normal pregnancy and impact on diabetic control.

All right, let's pivot to the physiological tug of war.

How does the body's need for insulin change across the trimesters?

Because this really creates a management tightrope for women with diabetes.

It's a journey of extremes.

It really is.

In the first trimester, we actually see a state of enhanced deficiency.

More efficient?

How so?

Well, the rising levels of estrogen and progesterone actually stimulate the pancreas.

So it increases insulin production and it significantly improves the body's peripheral sensitivity to insulin.

Which means the body needs less insulin to do the same job.

Exactly.

And this results in a physiological drop in fasting glucose levels, often by about 10%.

So the initial danger for an insulin -dependent woman is actually hypoglycemia, the opposite of what most people would expect.

Precisely.

The early risk is hypoglycemia.

And this is often compounded by the fact that many women have nausea and vomiting, so their food intake is down.

So clinically, this usually means we have to reduce her insulin dose, sometimes by 10 to 25%, to stop her from having these dangerous drops in blood sugar.

But this relative calm doesn't last.

By the second and third trimesters, the system completely shifts.

This is what we call the diabetogenic effect of pregnancy.

What's driving that massive change?

The placenta.

It's all about the placenta.

As the placenta matures and grows, it starts pumping out increasingly large amounts of insulin antagonistic hormones.

The heavy hitters.

The heavy hitters.

Human chorionic somatomamotropin, or HCS, estrogen, progesterone, prolactin, cortisol, plus an enzyme called insulinase.

And these hormones are actively working against the insulin.

They are.

They interfere with insulin binding at the cellular level.

And that causes profound insulin resistance.

Which, if you think about it from an evolutionary perspective, is actually a brilliant design.

It is.

It's a critical glucose sparing mechanism for the fetus.

The mother cells become less efficient at pulling glucose from her blood.

So that a constant robust supply can be shunted across the placenta to the growing baby.

Exactly.

But for the diabetic mother, her system is now fighting her insulin treatments tooth and nail.

And when does this resistance really start to kick in?

Typically, you start to see it around 18 to 24 weeks gestation.

And from that point on, the maternal insulin requirements just climb steeply.

How steeply?

By the time a woman reaches 36 weeks, it is not at all uncommon for her insulin needs to have doubled, tripled, or even quadrupled compared to what she was taking before pregnancy.

That is the physiological peak of insulin resistance.

Then we hit the peripartum and postpartum period.

And the sources describe this like an abrupt cliff drop What causes that almost immediate reversal?

The expulsion of the placenta.

That's the great equalizer.

As soon as the placenta is delivered, the major source of all those insulin antagonistic hormones is immediately and abruptly gone.

Just removed from the system?

Removed.

The half -lives of those hormones are pretty short, which means the insulin resistance that defined the second and third trimesters just gannishes almost instantly.

Which means the immediate postpartum danger shifts right back and violently to hypoglycemia.

It does.

For a non -breastfeeding woman, her insulin needs typically get back to pre -pregnancy levels within about 7 to 10 days.

And for breastfeeding moms?

That's a little different.

The sources point out that lactation itself is a glucose -consuming process.

So breastfeeding women often maintain lower insulin needs, sometimes 25 % less than their pre -pregnancy dose, until they wean.

Which requires constant careful management by the nursing staff.

Constant.

You cannot take your eye off the ball.

This volatility really underscores why preconception counseling is just so vital.

What specific outcomes are improved by planning and getting that glycemic control before conception?

Counseling allows the woman to achieve that golden standard HbA1c of less than 6 .5 % before organogenesis even begins.

Before the baby's organs start forming.

Right.

And this preconception planning is directly correlated with a massive reduction in perinatal mortality and a huge decrease in the incidence of congenital anomalies.

And a secondary goal.

A secondary goal is to diagnose any existing vascular damage, the nephropathy or retinopathy,

so that management can be tailored from day one of pregnancy.

Let's try to clearly connect poor control to specific maternal complications based on the timing.

Okay.

So poor control in the first trimester, that's the time of active organ formation, is linked to a much higher risk of spontaneous miscarriage.

And later in pregnancy?

Poor control later in pregnancy, especially women who don't have pre -existing vascular disease, is the primary driver of fetal macrosomia.

Macrosomia, which is a birth weight over 4 ,000 or 4 ,500 grams.

Why is that size itself so problematic during labor?

It's not just about the absolute weight, it's the disproportionate growth.

Maternal hyperglycemia acts like a growth hormone on the fetus.

Okay.

It causes excessive fat and glycogen to be stored.

Particularly in the shoulders and the trunk.

This disproportionate size increases the risk for really serious delivery complications, operative vaginal births, C -sections, and the really devastating complication of shoulder dystocia, where the baby's shoulder gets stuck behind the maternal pubic bone.

We also see higher rates of hypertensive disorders in these pregnancies.

Yes.

Women with pre -existing diabetes already have about a 15 to 30 percent risk of developing hypertension.

And if they have other issues?

If they also have co -existing renal or retinal vascular disease, that risk for developing superimposed preeclampsia just skyrockets.

It can be as high as 40 percent.

Another common consequence is hydramnios, or polyhydramnios, too much amniotic fluid.

What's the cause and effect link here, and why is that dangerous?

Polyhydramnios, which we define as an amniotic fluid index, or AFI, greater than 24 centimeters, it often develops in the third trimester.

And the theory is pretty direct.

High sugar leads to?

A high maternal and fetal glucose leads to high glucose in the amniotic fluid.

This makes the fetus produce excess urine -fetal polyuria, which compounds the fluid volume.

And that over -distends the uterus.

Right, which increases the risk of premature rupture of membranes, placental abruption, uterine dysfunction during labor, and a major, major risk of postpartum hemorrhage, because the uterus is just too stretched out to contract well.

We also noted that infections are more common.

And that brings us directly to the most critical metabolic emergency.

Diabetic ketoacidosis, or DKA?

DKA is a true emergency.

It usually happens in the second or third trimester, and it's triggered by stress, illness, or, most often, an infection.

And here's the absolute safety alert for clinicians.

Yes.

DKA can occur in pregnant women at blood glucose levels that are just barely over 200mgDL.

That is so much lower than the 300 -350mgDL we typically see in a non -pregnant adult.

Why is a specific threshold difference so important for practice?

It means you cannot rely on the classic signs of extreme, runaway hyperglycemia.

A pregnant patient who comes in with a blood sugar of, say, 210mgDL, and she's nauseous, vomiting, or breathing rapidly.

You have to immediately check for ketones.

Immediately.

Because metabolic acidosis can set in much, much faster.

An untreated DKA carries a significant risk of intrauterine fetal to death due to that maternal acidosis.

Okay, so let's look at the flipside managing hypoglycemia.

The risk for maternal hypoglycemia is also increased, particularly in that first trimester or overnight.

But is it as dangerous for the fetus?

Reassuringly, the sources note that mild or moderate hypoglycemic episodes, while they're very frightening for the mother, they don't appear to be severely damaging to the fetus's well -being.

Okay, so let's summarize the key differences in nursing interventions for these two emergencies.

This is classic testable knowledge.

For sure.

So, for hypoglycemia, which is less than 70mgDL, the onset is rapid.

The woman presents with those classic symptoms.

Shaking, sweating,

pallor, irritability.

And the intervention is just as rapid.

The rule of 15.

Give 15g of simple carbohydrate,

4oz of juice or regular soda, and then recheck her blood sugar in 15 minutes.

And if she's unconscious.

Priority is always airway.

Then you administer 50 % dextrose 5e push, or if there's no IV access, 1mg of glucagon intramuscularly.

And for hyperglycemia and DKA, which is over 200mgDL with ketones, the onset is much slower.

Great.

It evolves over hours or even days.

You're looking for thirst, nausea and vomiting, abdominal pain, those deep, rapid two -small respirations, and that fruity acetone odor on the breath.

And the priorities here are notification, aggressive hydration, and insulin.

Absolutely.

The patient needs immediate IV fluids, usually normal saline or half -NS, to address the massive dehydration.

Then you start insulin, often by an IV infusion.

And what about electrolytes?

Critically important.

You have to store potassium replacement once you know she has adequate urinary output.

Because insulin shifts potassium back into the cells, and you can cause a dangerous hypokalemia.

Okay, shifting to the fetal and neonatal risks.

The main cause of congenital malformations is, again, maternal hyperglycemia during the first trimester.

Right when the cardiovascular and central nervous systems are forming.

What are the most common anomalies we see?

Cardiac defects and neural tube defects are the most common.

Later in pregnancy, the maternal hyperglycemia drives fetal hyperinsulinism.

Meaning the fetal pancreas starts over -secreting insulin.

Right.

It gets active around 10 to 14 weeks.

Yeah.

And it's just churning out insulin in response to that high maternal glucose load.

And as we said, insulin acts as a powerful growth hormone on the fetus.

Exactly.

Leading to macrosomia, increased fat storage, and a large liver.

And this all predisposes the newborn to birth injuries.

And then immediately after birth, the glucose supply is cut off.

The maternal glucose supply from the umbilical cord is gone, but the newborn's hyperinsulinemic state is still there.

Causing a significant and rapid neonatal hypoglycemia.

A very dangerous drop in the newborn's blood sugar.

So the antipartum management is really this constant balancing act aimed at achieving and maintaining euglycemia.

Let's start with that baseline assessment.

The initial visit is very thorough.

You need a full physical exam, specifically looking for any signs of vascular damage,

or nopathy, nephropathy, neuropathy.

And labs.

We get a 24 -hour urine collection to assess total protein and creatamine clearance.

That gives us a baseline of her renal function.

And UTI screening is mandatory because of the increased risk of infection.

We also use the glycosylative hemoglobin A1C.

What's the target and what's the clinical catch when we use A1C in pregnancy?

The target is less than 6 .5 % for the lowest rates of anomalies.

The catch is that pregnancy causes a faster turnover of red blood cells.

Ah, so the A1C reflects a shorter time window.

Exactly.

An A1C that typically reflects the last three months only reflects about the last two to six weeks of glucose control in a pregnant woman.

And there's an important safety alert about anemia.

A very important one.

Iron deficiency anemia can actually falsely increase the A1C level.

So you have to account for that when you're interpreting the results.

So what are the specific target plasma glucose levels we're aiming for?

These are much tighter than the non -pregnant goals.

Much tighter.

We're aiming for a fasting glucose between 60 and less than 95 mL of GDL.

And post -meal.

The one -hour post -meal level needs to be less than 140 mL of GDL.

And the two -hour post -meal level has to be less than 120 mL of GDL.

Dietary management is the absolute mainstay, and it's individualized by a registered dietitian.

We spread calories across three meals and three snacks.

Why is the emphasis on small frequent meals and never skipping one?

The goal is to maintain stable plasma glucose and prevent those big swings.

Never going more than four hours without food is essential, because prolonged fasting just increases the risk for hypoglycemia.

Which leads to a very specific nursing teaching point.

The bedtime snack.

Yes, the bedtime snack is critical.

It's required to prevent two problems overnight.

And it has to be a specific type of snack.

It does.

Has to be a large snack.

At least 25 grams of a complex carbohydrate combined with a protein or a fat.

Why that combination?

It prevents both nocturnal hypoglycemia and the subsequent risk of starvation ketosis.

Which happens when the body starts breaking down fats overnight because it's run out of fuel.

Okay, let's talk exercise.

It's encouraged 30 to 60 minutes a day for its benefit on insulin sensitivity.

But there are some critical safety rules around it.

Three main alerts.

First,

she has to check her blood glucose before and after she exercises.

If the reading is less than 100 before she starts, she must eat 15 to 30 grams carbohydrate without taking any insulin.

Second, she must avoid exercise entirely if her blood glucose is greater than 200.

Or if she has positive urine ketones.

Why is that?

Because physical activity in a state of relative insulin deficiency will actually worsen the hypoglycemia and can push her toward ketosis.

And the third alert.

She has to stop immediately if she detects any uterine contractions as that could signal preterm activity.

Now insulin therapy.

We noted the dose changes are massive, peaking at 36 weeks.

What are the common modern regimens?

Multiple daily injections or MVI is the standard.

These regimens often combine an intermediate acting insulin like NPH with a rapid acting analog like Lispro or Aspart which she takes right before meals.

And the advantage of those rapid acting insulins is their quick onset.

About 15 minutes.

It allows for immediate meal dosing and their short duration, about three to five hours,

minimizes the risk of delayed hypoglycemia hours later.

And for basal or background coverage?

We use long acting insulins like Glargine or Detemir.

They don't have a pronounced peak, so they provide consistent coverage for up to 24 hours.

And there's a crucial administration teaching point about Glargine.

The very important one.

Glargine insulin is acidic and it absolutely cannot be mixed in the same syringe with any other type of insulin.

What are the best practices for injection sites?

The abdomen is the preferred site because it has the most consistent absorption.

And rotation is key.

The patient should inject about two inches away from the previous site within one specific quadrant before moving to a completely new quadrant.

And what about the higher tech options like insulin pens and pumps?

Insulin pens are great for convenience, accuracy, and they're less painful, which helps with compliance.

The continuous subcutaneous insulin infusion system, or pump, is used for highly motivated and well -trained women.

And how does the pump work?

It uses only rabid acting insulin and it delivers a continuous basal rate that's tailored to her specific needs, which can be highly effective.

But there's a risk.

There is.

If the pump malfunctions or the catheter gets kinked, the lack of any basal insulin can lead to a very rapid and potentially very severe state of DKA.

Regarding self -monitoring, how often are women checking their blood sugar?

And what are the key clinical takeaways from those checks?

Home monitoring, usually six to eight times a day, is a standard of care.

So fasting one or two hours after each meal and at a bedtime.

And the nursing alert we need to reinforce.

Hyperglycemia is most likely to show up in the two -hour post -meal values.

That's when the meal absorption has outstripped the peak action of the short -acting insulin.

And urine testing?

We don't test for glucose, but ketone testing is still useful.

Urine glucose testing is basically useless because the renal threshold is lowered in pregnancy.

But urine ketone testing is vital when the woman is sick, if she skipped a meal, or if her blood glucose is over 200.

It's an early warning system for ketoacidosis.

Finally, fetal surveillance.

Given all these risks, when does it start and what are we looking for?

Surveillance is intense.

You get an early baseline ultrasound for dating.

Then you repeat ultrasounds every four to six weeks to monitor for growth, hydraminoids, and macrosomia.

And screening for defects.

Because of the higher risk of neural tube defects, or NTDs, we check a maternal serum alpha -feta protein between 15 and 20 weeks.

And the cardiac screening.

If a woman enters pregnancy with really poor control, say an A1c over 10%, the risk for congenital cardiac anomalies is so high that it mandates a fetal echocardiogram between 20 and 22 weeks.

And in the third trimester.

We start twice -weekly non -stress tests, or NSTs, and biophysical profiles, BPPs, usually by 32 weeks.

Especially if the mother has any vascular disease or her control isn't great.

Birth timing is ideally scheduled for 39 weeks if glycemic control is optimal.

Yes.

But if delivery has to happen earlier, especially before 38 weeks, we need an amniocentesis to confirm fetal lung maturity.

Specifically, we're looking for the presence of phosphatidal glycerol, or PG.

And the C -section rate is quite high.

It is, often up to 80%.

And a prophylactic C -section is often considered for an estimated fetal weight of 4 ,500 grams or more, just to mitigate that risk of shoulder dystocia.

Okay, moving into labor and birth.

The goals remain tight control.

The sources emphasize a very narrow target glucose range of 90 to 110 mL GYDL.

Why is keeping glucose this tight during labor so important for the baby?

Because hyperglycemia during labor is the direct cause of neonatal hyperglycemia immediately after birth.

How so?

If the mother's blood sugar is high, the baby's pancreas is just working over time hypersecreting insulin.

Then the cord is cut.

And that high insulin level remains.

But the glucose supply from mom vanishes.

This causes a dangerous precipitous drop in the newborn's blood sugar.

So what are the main nursing interventions during active labor to manage this?

We use IV fluids, usually normal saline.

We might piggyback 5 % dextrose, but only once active labor starts, or if a glucose drops below 70.

And if it goes too high?

If a glucose level goes above 110, we administer short -acting insulin by continuous 5E infusion.

And of course, continuous FHR monitoring is mandatory.

Positioning is also critical.

Yes.

Upright or sidelining to prevent supine hypotension, which is very common with a large macrosomic baby or polyhydramnios.

Postpartum is the next major shift.

How dramatically do insulin needs change?

Dramatically.

The moment the placenta is expelled, the dose has to be rapidly reduced.

The dose is usually restarted at her pre -pregnancy level, or maybe one -half to one -third of the pregnancy dose when she's eating again.

And women with type 2 can usually go back to their oral meds.

Yes.

As long as they're compatible with breastfeeding, they can usually transition back to oral hypoglycemics.

Postpartum complications are also higher for these women.

They are.

That large, over -distended uterus from macrosomia or polyhydramnios puts them at a much higher risk for uterine adenine and postpartum hemorrhage.

And other risks.

They also have an elevated risk for preeclampsia and infection, particularly endometritis.

We encourage breastfeeding for its metabolic benefits, but it introduces yet another hypoglycemia risk.

It does.

Breastfeeding uses maternal glucose, which reduces her insulin requirements.

So the safety alert is to check her blood glucose immediately before nursing.

And if it's low.

If her glucose is less than 100, she needs to eat 15 grams of carbohydrate without taking any insulin.

This prevents a hypoglycemic episode that could compromise her well -being or even reduce her milk supply.

Finally, long -term family planning is essential, given the risks of subsequent pregnancies.

Absolutely.

Barrier methods are always safe.

Combined low -dose oral contraceptives are a bit controversial because of the thromboembolism risk, but they might be used by nonsmokers who don't have vascular disease.

What's often recommended?

Long -acting reversible contraception, or LRACISO, IUDs, and implants.

They're highly effective.

And for women with severe preexisting vascular disease,

those Class F, R, or T patients' sterilization is often the most appropriate recommendation once their family is complete.

Hashtag, tag, tag, tag, 1 .6 gestational diabetes, mellitus, GDM.

All right.

Let's quickly review GDM.

It's less risky than pregestational DM, but it still carries significant maternal and fetal complications.

Right.

Maternally, GDM increases the risk for preeclampsia and c -section.

And there's a frightening long -term statistic.

Up to 70 % of these women will eventually develop type 2 diabetes later in life.

70%.

And the fetal risks are macrosomia, birth trauma, and neonatal hypoglycemia, just like in pregestational DM.

But there's a crucial distinction in the fetal outcomes.

Yes.

Infants of women with GDM do not have an increased risk of congenital defects.

Why not?

Because the condition only shows up after the critical period of organogenesis is already complete.

It's diagnosed in the second or third trimester.

Screening happens early for high -risk women, but for the general population, it's between 24 and 28 weeks.

And this is where we see that clinical conflict between ACOG and ADA guidelines, the two -step versus the one -step method.

Yeah, this is a complex area in practice.

ACOG has traditionally favored the two -step method.

Which starts with?

Step one is a non -fasting 50 -gram glucose screen.

If that one -hour result is 130 to 140 or higher, then she moves to step two.

And step two is the big one?

That's the three -hour, 100 -gram oral glucose tolerance test, or OGTT, which requires an overnight fast.

And you make the diagnosis if two or more of the values are met or exceeded.

Okay.

And the alternative is the one -step method, which is preferred by the ADO.

Right.

This uses a 75 -gram OGTT, and the diagnosis is made if only one value is met or exceeded.

So what's the clinical implication of that difference?

Well, the one -step method uses lower thresholds, which means it significantly increases the diagnosis rate.

You might identify twice as many women with GDM using that method.

And the debate continues over whether that benefit of early detection outweighs the potential for over diagnosis.

Management for GDM focuses first on diet and exercise to meet those tight glycemic goals.

Diet modification is the absolute mainstay.

Weight reduction is recommended for overweight or obese women, along with a moderate exercise program of about 150 minutes per week.

And if that fails?

If diet and exercise aren't enough, then pharmacologic intervention begins.

Insulin is the ADA's preferred agent, but oral agents are very common.

What are the pros and cons of the most used oral drugs?

So metformin and gliboride are used, even though they don't have a specific FDA approval for GDM.

How do they work?

Metformin decreases glucose production in the liver and increases the body's sensitivity to insulin.

Glyboride, which is the most common one used in the US, stimulates the maternal pancreas to produce more insulin.

And the preference?

The preference often leans toward insulin or even something like buprenorphine, because they don't cross the placenta as readily as some oral agents.

But metformin and gliboride are definitely being used more and more.

Fetal surveillance for GDM is less intense than for pregestational DM.

It's not routine for women who are just diet controlled.

But for those who need medication or if hypertension or macrosomia develops, then testing like NSTs and BPPs often begins around 32 weeks.

And the postpartum follow -up is essential for preventing that future type 2 diabetes.

It's so important.

While most women's glucose levels normalize quickly, up to a third will show impaired tolerance or even have outright diabetes.

So they need to be tested.

They must be assessed with a 75 -gram OGDT or a fasting glucose test about 4 to 12 weeks postpartum.

And they require lifelong screening every three years.

Proactive lifestyle changes, weight loss and exercise, are proven to significantly lower that risk of developing type 2 DM.

Okay, let's transition into other endocrine disorders, starting with the thyroid.

Pregnancy itself creates a real diagnostic challenge because of the hormonal environment.

It's a classic overlap of symptoms.

The high level of HCG in early pregnancy actually stimulates the TSH receptors, which naturally lowers the TSH reference range.

And the symptoms themselves are confusing.

Symptoms of both hypo and hyperthyroidism, things like fatigue, anxiety, palpitations, are often just dismissed as normal pregnancy complaints.

So you have to rely on the labs.

You have to rely heavily on objective lab findings, T4, T3, TSH, and specific signs like a goiter or a persistent pulse rate over 100 beats per minute.

For hyperthyroidism, which is usually Graves' disease, what are the maternal risks if it's left untreated?

The risks include miscarriage, preterm birth, preeclampsia, and even maternal heart failure.

And the management is difficult because of the safety profile of the required drugs.

Propylthia, Cil, PTU, and Methamazole, MMI.

Right.

And this is where we see a mandatory drug switch protocol.

Walk us through the rationale for that.

It's a complex trade -off.

It is.

So the FDA and the American Thyroid Association recommend using PTU only during the first trimester.

Why only in the first?

Because MMI has been associated with fetal teratogenicity.

Specifically, it can cause cardiac defects, coenal atresia, and esophageal atresia when it's used during that critical period of organogenesis.

So MMI is avoided early, but then PTU carries its own risk later on.

Exactly.

PTU carries a risk of severe maternal hepatic toxicity, or liver damage, which increases later in gestation.

So women are switched to MMI after the first trimester.

And the goal is always to use the lowest effective dose.

Right.

You taper the dose down to manage the mother's hyperthyroidism while also preventing fetal hypothyroidism.

And what about the rare, potentially fatal, emergency?

Thyroid storm.

It's often triggered by stressors like infection, labor, or surgery.

It presents with fever, extreme restlessness, severe tachycardia, vomiting, and it can lead to cardiac collapse.

And treatment has to be immediate.

Immediate.

It involves IV fluids,

oxygen, high dose PTU, then iodide, antipyretics, dexamethasone, and beta blockers to control that severe sympathetic response.

Postpartum, what about breastfeeding safety?

Generally, low doses of these medications are considered safe.

Breastfeeding is allowed if the PTU dose is less than 300 milligrams per day, or the MMI is less than 20 milligrams per day.

Okay.

Moving to hypothyroidism, which is often caused by Hashimoto's Thyroiditis.

The signs are lethargy, weight gain, cold, and tolerance with an elevated TSH and a low T4.

And untreated hypothyroidism significantly increases the risks for miscarriage, preeclampsia, placental abruption, and stillbirth.

Treatment is simply levothyroxine or T4 supplementation.

You adjust the dose to keep the TSH at the lower end of the normal range for pregnancy.

And there is a critical medication instruction for the patient.

A very critical one.

Levothyroxine absorption is significantly impaired by iron.

Nurses must instruct the patient to take her levothyroxine at least four hours apart from her iron supplements.

And that includes prenatal vitamins that contain ferrous sulfate.

To make sure she's getting a therapeutic dose.

Exactly.

And it is safe for breastfeeding.

Lastly in this section, maternal phenylalanine hydroxylase deficiency, PAH or PKU.

This is an inborn error of metabolism affecting protein.

Right.

In the absence of the PAH enzyme, phenylalanine, which is found in all protein foods, just accumulates to toxic levels.

For a woman with PKU, the goal is a lifelong dietary restriction.

And the absolute key takeaway here is the need for rigorous preconception control.

It is the most important thing.

What are the required levels and why is that strict control so critical for the fetus?

Maternal phenylalanine levels have to be maintained in a very, very tight range.

Between two and six mil of GDL for at least three months before she conceives and then throughout the entire pregnancy.

And if they're too high.

If the maternal levels are too high, the accumulated phenylalanine is highly teratogenic to the developing fetus.

It leads to severe fetal sequelae, profound intellectual disability, microcephaly, seizures, growth impairment, and congenital cardiac anomalies.

The goal is to minimize that transfer to the baby.

Now we come to what is maybe the most precarious system during pregnancy, the heart.

A normal pregnancy is a state of extreme hemodynamic stress.

How does pregnancy physiologically challenge the cardiovascular system?

It just massively increases the hemodynamic workload.

The intravascular volume goes up by 40 to 50 percent.

Systemic vascular resistance drops significantly and cardiac output surges by 30 to 45 percent.

And that output peaks relatively early.

It does between 20 and 26 weeks of gestation.

So a heart that is already compromised has to handle an extra 40 percent volume and a huge increase in output.

This puts it at high risk for cardiac decompensation.

Which is the inability to maintain sufficient output.

And the sources are very clear on this.

Infection and fever are listed as the major causes of cardiac decompensation during pregnancy.

Which means early detection and aggressive treatment of any infection are critical nursing priorities.

We use the New York Heart Association, or NYHA, functional classification to assess risk, ranging from class one, which is asymptomatic, to class four, symptomatic at rest.

Why do we have to reassess this multiple times during pregnancy?

Because the hemodynamic state is so dynamic.

A woman who has a comfortable class wheeze early on might rapidly progress to a class two or even a class three as that cardiac output peaks around 20 to 26 weeks.

Oh, you've got to keep checking.

You reassess around three months and then again at seven or eight months to make sure the management plan reflects her current cardiac reserve.

Women in class three or four carry the highest mortality risk and require the most intensive interventions, often including hospitalization.

Hashtag tag tag 3 .2 congenital and acquired cardiac lesions.

Let's discuss some of the specific lesions.

For small corrected septal defects like an ASD or a PDA, what's the key management focus?

While they're generally uncomplicated, the main priority is thromboembolic prophylaxis.

Preventing blood clots.

Right, because of the increased risk of clot formation associated with the altered flow dynamics and just the general hypercoagulable state of pregnancy.

Coarctation of the aorta is a narrowing that, if it's uncorrected, risks catastrophic events like aortic dissection or hemorrhagic stroke.

Yeah, so management there involves rest and antihypertensives, preferably beta blockers, to keep the blood pressure regulated and minimize stress on that aortic wall.

And for delivery.

Vaginal delivery is preferred, but we need a shortened second stage, often using forceps or a vacuum and a good epidural to prevent those blood pressure spikes that come with maternal pushing.

Tetralogy of phallate is the most common cyanotic heart disease.

When is the period of greatest danger for these women?

The late third trimester and, crucially, the early postpartum period.

Why then?

Because any rapid drop in systemic vascular resistance or venous return can increase that right -to -left shunting, which leads to severe hypoxemia.

So management is all about maintaining venous return.

Exactly.

Grated support hose, avoiding sudden position changes, and prophylactic antibiotics during labor to prevent endocarditis.

For acquired diseases, mitral stenosis, often from rheumatic heart disease, is particularly worsened by the massive volume increase of pregnancy.

It is.

Because that narrow valve obstructs outflow, the high pregnancy volume can easily back up, leading to pulmonary edema, atrial fibrillation, and heart failure.

So management is very restrictive.

Very.

Strict activity restriction, sometimes hospitalization for class three and four, sodium restriction, and diuretics.

And intrapartum, the side lying position, is critical.

You must absolutely avoid the supine or lithotomy position.

Because that immediately increases venous return.

And can risk rapid pulmonary edema.

What about a myocardial infarction, or MI?

It's rare, but it most often occurs in the third trimester or postpartum.

The treatment is pretty standard morphine, nitrates, beta blockers, aspirin, and again, vaginal birth is preferred, but you want to avoid active maternal pushing.

So forceps or vacuum again.

To assist the delivery and shorten that second stage, hashtag, tag, tag, 3 .3, high mortality conditions and special cases.

Some conditions present such a high risk that pregnancy is generally advised against.

Primary pulmonary hypertension, or PPH, is the prime example.

PPH carries a maternal mortality weight that approaches 50%.

50%.

The fundamental problem is severe resistance in the lung vasculature.

So the right side of the heart is under immense strain.

For these patients, the absolute safety goal is avoiding hypotension.

Any drop in blood pressure is catastrophic.

Catastrophic.

Management involves strict bed rest, supplemental oxygen, and extreme caution with an epidural to prevent a sudden drop in systemic vascular resistance.

And Marfan syndrome, which is related to connective tissue weakness, often risks aortic dissection.

Right.

If the aortic root diameter reaches four centimeters or more, the mortality risk increases significantly, and pregnancy is generally not recommended.

Management requires restricted activity and using beta blockers to keep the heart rate low, ideally around 70 beats per minute, to reduce that sheer stress on the aortic wall.

Women with valve replacements require intense anticoagulation management.

This is navigating a dangerous tightrope between hemorrhage and thromboembolism.

This is one of the most complex clinical management scenarios you can have.

Because warfarin, or Coumadin, is teratogenic in the first trimester, we often start with low molecular weight heparin, like Levinox.

Then you can switch to warfarin.

You might use warfarin in the second, third trimesters, but then you have to switch the mother back to unfractionated heparin as delivery gets closer to minimize the hemorrhage risk during labor.

Is warfarin safe postpartum?

Yes.

It's safe for long -term postpartum use and for breastfeeding.

Since early intervention is so important, what are the key subjective signs of cardiac decompensation that nurses have to teach their patients to recognize and report immediately?

This is all about anticipatory guidance.

We teach them to watch for symptoms that are different from normal pregnancy fatigue, increasing fatigue or shortness of breath with activities that were previously easy, a frequent persistent cough, palpitations, and generalized edema -like, a sudden inability to wear her rings or shoes.

Objectively, what should the nursing assessment reveal?

A rapid irregular or weak pulse, over 100 beats per minute, rapid respirations, over 25 breaths per minute, crackles or moist rails at the lung bases that don't clear with a cough,

progressive generalized edema, and any signs of cyanosis.

Any of these require immediate action.

Antipartum, minimizing stress and treating infections promptly are key.

We also noted a very specific maneuver that has to be avoided.

The Velsalva maneuver.

Straining against a closed glottis, especially during a bowel movement, it must be avoided at all costs.

Why is it so dangerous?

It dangerously increases interthoracic pressure, which drastically reduces venous return.

Then when she releases, there's a sudden massive surge of blood back to the heart, which can easily overload a compromised ventricle.

So patients need to be taught prevention.

High fiber diet, plenty of fluids, and stool softeners.

Intrapartum, safety is all about continuous monitoring.

Epidural analgesia is encouraged.

Epidurals are highly beneficial because they reduce that pain -induced cardiac stress, but they have to be managed very carefully to avoid hypotension.

Positioning is crucial.

Head and shoulders elevated, side lying is preferred.

And there's a critical drug safety alert.

We must avoid beta -adrenergic agents like turbutaline, which are sometimes used for They cause tachycardia and increase myocardial oxygen demand, which can risk decompensation.

And the delivery technique.

We recommend open glottis, pushing to avoid that Valsalva maneuver.

The second phase should be shortened with a vacuum or forceps.

And postpartum, we have to avoid ERGOT products like MetherGene for hemorrhage control.

Because they increase blood pressure?

They cause severe peripheral vasoconstriction and raise the blood pressure, Dangerously increasing the heart's workload.

Hashtag tag tag 3 .5 postpartum safety.

The most dangerous time.

This brings us to the most hazardous period.

The immediate 24 to 48 hours postpartum.

If the mother has made it through labor, why does the risk surge right now?

It's the period of highest hemodynamic demand.

Once the placenta and the fetus are delivered,

that intra -abdominal pressure is reduced.

This allows for a rapid return of blood from the lower extremities back into the central circulation.

And there's a fluid shift.

Massive one.

The extravascular fluid that mobilized during pregnancy rapidly shifts back into the vascular compartment.

This leads to a huge rapid increase in circulating blood volume, which can easily overwhelm a compromised heart.

So nursing care during this critical window is all about vigilance and reducing workload.

Absolutely.

We're continuously monitoring for any signs of decompensation.

The woman is kept on bed rest with the head of the bed elevated, usually in a side lying position.

Pain management and anxiety control are critical.

And breastfeeding.

It's encouraged, as most cardiac meds are compatible, but she will need physical assistance to conserve her energy.

We also have to watch for a decreased milk supply if diuretics like Lasix are being used.

And for long -term family planning.

Again, LARC methods, IUDs, and progestin implants are highly effective and often the preferred choice.

Combined oral contraceptives are generally contraindicated in high -risk women because of that thromboembolism risk.

Let's look at other major systemic challenges, starting with anemia, which affects a huge percentage of pregnancies globally.

It does.

Anemia, which we define as a hemoglobin less than 11 in the first and third trimesters, or less than 10 .5 in the second, increases the cardiac workload.

The heart has to pump faster to compensate for that reduced oxygen carrying capacity.

And it combined with other issues.

It can risk congestive heart failure.

Iron deficiency anemia is the overwhelming majority of cases.

How do we definitively diagnose it?

The diagnosis rests on a low hemoglobin combined with a low serum ferritin, specifically less than 12 mL CGL.

It's associated with preterm birth and low birth weight.

And treatment is iron supplementation.

Right, 325 mg of ferrous sulfate twice a day.

And nursing teaching has to address the common side effects.

GI upset, constipation, and dark stools.

And we need to emphasize the need for increased fluids and fiber.

We also address folic acid deficiency, which causes megaloblastic anemia.

And folic acid needs to just soar in pregnancy, up to 600 mcg a day.

High -risk women, like those on anticonvulsants or with twins, require even higher doses.

And what about the unique considerations for sickle cell anemia?

This is a hereditary hemolytic anemia, where crises are triggered by things like dehydration, hypoxia, or acidosis.

The risks include preeclampsia, IUGR, and stillbirth.

And there's a critical safety alert for nursing care here.

A very important one.

You must avoid routine iron supplementation.

And that includes the iron in prenatal vitamins.

Why is that?

Sickle cell patients are not iron deficient.

They are prone to iron overload because of chronic hemolysis.

And that overload can damage their organs.

They only need folic acid supplementation.

Switching to pulmonary disorders, asthma affects 4 -8 % of pregnancies with unpredictable effects.

Severe asthma is linked to higher rates of preterm birth, preeclampsia, and IUGR.

The goal is always prevention of exacerbations, using objective measures like FEV or peak flow to guide care.

Inhaled corticosteroids are still the preferred treatment.

And intrapartum, we have to be vigilant about hemorrhage medications.

Absolutely.

The powerful vasoconstrictors we use for postpartum hemorrhage carboprost, hemabate, and methylgine are contraindicated because they can trigger severe bronchospasm in asthmatic patients.

For cystic fibrosis, CF, the severity of the disease really dictates the risk.

That's right.

Women with mild disease and good nutrition often tolerate pregnancy quite well.

But severe disease carries risks of chronic hypoxemia, frequent infections, and IUGR.

Management requires a very high caloric intake.

About 24 to 26 pounds of weight gain is recommended.

And careful adjustment of their pancreatic enzymes.

Hashtags, tag, tag, 4 .3, enticometry, and neurologic disorders.

We have to start this section with a massive safety alert about skin care.

The common acne medication isotritinone.

Isotritinone, Accutane, is one of the most potent teratogens known to medicine.

It causes severe craniofacial, cardiac, and CNS malformations.

It is absolutely contraindicated in pregnancy and must be discontinued well before conception.

We discussed two common pruritic or itching conditions.

One is benign, the other is high risk.

Pruritus gravidarum is generalized itching without a rash, and it's usually benign.

The high risk one is intrahepatic cholestasis of pregnancy, or ICP.

And what is ICP?

It's a liver disorder that's defined by severe generalized itching, often worst on the palms and soles, elevated bile acids, and abnormal liver function tests.

And the fetal risk is significant.

Very significant.

Asphyxia, stillbirth, and preterm birth.

Treatment is ursodeoxycholic acid, and birth is often induced around 37 weeks if surveillance is reassuring.

Now to the nervous system, epilepsy is the most common major neurological disorder that complicates pregnancy.

Right, and seizure frequency tends to follow pre -pregnancy patterns, so getting control before conception is key.

The major risk factor is actually the anticonvulsant medication itself.

Because it increases the risk of congenital anomalies.

Like neural tube defects, clefs, and cardiac defects.

And there is one anticonvulsant that carries the most significant warning.

Valproic acid, Dipakote.

It is strongly associated with major malformations and really concerning adverse cognitive outcomes.

Like lower IQ scores and an increased risk for autism.

So the general rule is?

Use monotherapy at the lowest effective dose.

Monitor the drug blood levels closely because of the plasma volume changes.

And provide high dose folic acid supplementation.

Up to 4 or 5 milligrams a day.

Postpartum safety teaching related to epilepsy is intensely practical.

It is.

Sleep deprivation is a major seizure trigger.

The partner has to make sure the mother gets 6 to 8 hours of uninterrupted sleep.

And for infant care?

Nurses have to teach safety strategies.

Bade the baby only when another adult is present and critically change diapers on a mat placed on the floor, not on a changing table.

That prevents the infant from falling during an unexpected seizure.

Finally, multiple sclerosis MS.

MS involves demyelinization of the central nervous system.

Pregnancy often provides a welcome remission period.

But exacerbations are very common postpartum.

What about their medications?

Due to lack of safety data, most experts recommend stopping the disease modifying therapies, or DMTs, before conception.

Reassuringly, though, epidural analgesia during labor is considered safe.

We're going to conclude with the challenges of substance use disorder, or SUD.

It's a growing problem that's complicated by legal and social barriers.

Universal non -biased screening is recommended for all women, regardless of their background.

And nurses really need to create a safe environment for that screening.

Since women often underreport their use because they're afraid, screening should happen when the woman is alone.

And the questions should include pre -pregnancy use, as that tends to increase honesty.

What are some of the quick screening tools that are used?

The 4Ps Plus is very common.

It asks about parent problems, partner problems, past use, and pregnancy use.

For adolescents, the CREFFT questionnaire is effective.

That's car, relax, alone, forget, family, friends, and trouble.

The legal framework is probably the most significant barrier that prevents women from seeking care.

It is.

In many states, SUD in pregnancy is legally defined as child abuse, or mandatory reporting is triggered.

This creates a severe ethical and clinical conflict.

Because the fear of prosecution or losing custody is so powerful.

It's so powerful that women will actively avoid seeking vital prenatal care, which just worsens outcomes for both the mother and the child.

So informed consent should always be obtained before any toxicologic testing because of these massive legal implications.

And beyond the legal barriers, just getting access to treatment is difficult.

The barriers are widespread.

Social stigma, lack of insurance, long waiting lists, and critically, programs that fail to address the simultaneous needs of pregnant women, like getting obstetric care or child care.

Okay, let's quickly review the specific maternal and fetal effects of the most common substances.

Tobacco use is associated with a range of placental complications, IUGR, and low birth weight.

Alcohol has no known safe threshold in pregnancy.

It increases the risk of birth defects, particularly fetal alcohol syndrome.

And withdrawal requires inpatient management with benzodiazepines.

Marijuana is the most common illicit drug, and it's linked to IUGR.

The CNS stimulants, cocaine, and methamphetamines act as potent vasoconstrictors.

And that vasoconstriction is the direct cause and effect link for their associated risks.

You see an increased incidence of preterm labor, placental abruption, preeclampsia, IUGR, and congenital heart defects, especially with methamphetamines.

Immediate cessation is always advised.

For opioids, the standard of care is opioid agonist therapy, or OAT, or medication -assisted treatment.

Chronic opioid addiction is linked to IUGR, abruption, and intradermiconium.

Matt uses either methadone or buprenorphine.

And buprenorphine is increasingly favored.

It is, often combined with naloxone as suboxone.

It's favored because it can be managed as an outpatient, it has lower overdose risk, and it's associated with less severe neonatal abstinence syndrome, or NAS, for the infant compared to methadone.

And this is important.

Medical withdrawal is not recommended during pregnancy.

It's not.

Due to the high relapse rates and the risk of fetal distress that's caused by the withdrawal symptoms,

have tag tag tag 5 .3 nursing interventions and postpartum care.

The nursing stance here is just vital.

The sources clearly define SUD as an illness.

Nurses have to adopt a therapeutic, nonjudgmental approach.

You treat the woman with patience, kindness, consistency, and firmness when it's necessary.

And you do not withhold pain management.

You must not, under any circumstance, withhold necessary pain management during labor or postpartum because of an addiction history.

And using standardized care plans is essential to ensure consistent care and prevent staff manipulation.

Let's clarify the critical breastfeeding guidelines, especially for women in those IMAT programs.

Okay.

Breastfeeding is contraindicated for active users of methamphetamines, alcohol, cocaine, heroin, or marijuana.

However, breastfeeding is actively encouraged for women who are maintained on buprenorphine or methadone.

Why is that?

The transfer of the medication into the milk is minimal, and the act of breastfeeding has been shown to significantly decrease the severity of NAAS and shorten the infant's required hospital stay.

For smokers who choose to breastfeed, what is the specific, actionable teaching?

They should avoid smoking for at least two hours before a feeding.

This minimizes the nicotine transfer, and it can improve the milk letdown reflex.

And crucially, they must never smoke in the same room as the infant because of the established risk of respiratory issues from secondhand smoke.

Finally, before discharge, follow -up has to be diligent.

A home safety assessment is critical.

And if there are serious concerns about the infant's safety, a referral to Child Protective Services is mandatory to ensure the newborn's well -being.

That was a tremendous deep dive, moving us so rapidly from cellular physiology all the way to complex social and legal challenges and high -risk care.

Let's recap the three highest -yield nursing priorities for you, the clinician.

First, metabolic control.

You have to memorize those tight glycemic targets fasting under 95, one hour under 140.

And recognize that crucial safety alert about DKA.

It happens at a much lower threshold, over 200 mL GDL in pregnancy.

And be prepared for that dramatic drop in insulin needs the moment the placenta is out.

Second, hemodynamic vigilance.

You must be acutely aware of the signs of cardiac decompensation, especially during that peak stress period, 20 to 26 weeks, and those critical first 48 hours postpartum.

Always remember the high -yield interventions, treat infections promptly, avoid the Valsalva maneuver, and manage pain carefully.

And third, non -judgmental SUD care.

Use universal non -biased screening.

Advocate for and provide patient -centered opioid agonist therapy, or OAT, as the standard of care.

And recognize that those legal barriers often prevent women from seeking help.

Your consistent non -judgmental stance is indispensable for promoting mother -infant attachment and safety.

What's fascinating to me here is the sheer velocity of change.

When you overlay these chronic sort of static conditions like diabetes or heart disease onto the hyperdynamic, rapidly evolving physiology of pregnancy, the management window just shrinks dramatically.

It really does.

It creates a clinical environment where there is simply no room for error.

It demands meticulous attention to detail, constant physiological reassessment, and above all, seamless interprofessional teamwork to ensure safety and positive outcomes for two patients instead of just one.

That's a powerful thought to leave us with.

Thank you for diving deep with us today.

Until next time.